Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 9:2022:7876030.
doi: 10.1155/2022/7876030. eCollection 2022.

Performance of the Colloidal Gold Immunochromatography of Cryptococcal Antigen on Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Cryptococcosis

Ning Zhu  1 , Shanhong Lin  2 , Xingbei Weng  3 , Weijie Sun  3 , Xueqin Chen  4
Affiliations

Performance of the Colloidal Gold Immunochromatography of Cryptococcal Antigen on Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Cryptococcosis

Ning Zhu et al. Can J Infect Dis Med Microbiol. .

Abstract

Objective: This study aimed to investigate the efficacy of the colloidal gold immunochromatography method in the detection of Cryptococcus antigen in bronchoalveolar lavage fluid (BALF) for pulmonary cryptococcosis (PC) diagnosis.

Methods: A total of 111 patients with clinically suspected PC who were finally diagnosed with nonhuman immunodeficiency virus infection and hospitalized in the Ningbo First Hospital from March 2017 to December 2021 were retrospectively analyzed. All the confirmed cases were divided into two groups as follows: the PC group (33 cases) and the non-PC group (78 cases). All the patients were subjected to serum and BALF cryptococcal capsular polysaccharide antigen-lateral flow immunochromatographic assay (CrAg-LFA) and etiological culturing.

Results: In the PC group, serum CrAg-LFA was positive for 24 and negative for 9 cases, serum Cryptococcus culture was positive for 1 and negative for 32 cases, BALF CrAg-LFA was positive for 31 and negative for 2 cases, and BALF Cryptococcus culture was positive for 9 and negative for 24 cases. In the non-PC group, serum CrAg-LFA was positive for 1 and negative for 77 cases, serum culture was negative in all the cases, and both BALF CrAg-LFA and culture were negative in all the cases. The sensitivity, specificity, and accuracy of BALF CrAg-LFA for PC diagnosis were 93.9%, 100%, and 98.2%, respectively, whereas those of BALF culture were 27.3%, 100%, and 78.4%, respectively. The sensitivity and accuracy of BALF CrAg-LFA were higher than that of serum CrAg-LFA and BALF etiological culture with statistically significant differences (p < 0.05).

Conclusion: The diagnostic value of BALF CrAg-LFA for PC is superior to that of serum CrAg-LFA and BALF etiological culture.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

References

    1. Setianingrum F., Rautemaa-Richardson R., Denning D. W. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Medical Mycology . 2019;57(2):133–150. doi: 10.1093/mmy/myy086. - DOI - PubMed
    1. Jitmuang A., Panackal A. A., Williamson P. R., Bennett J. E., Dekker J. P., Zelazny A. M. Performance of the cryptococcal antigen lateral flow assay in non-HIV-related cryptococcosis. Journal of Clinical Microbiology . 2016;54(2):460–463. doi: 10.1128/jcm.02223-15. - DOI - PMC - PubMed
    1. Jenks J. D., Mehta S. R., Taplitz R., Aslam S., Reed S. L., Hoenigl M. Point‐of‐care diagnosis of invasive aspergillosis in non‐neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus ‐specific Lateral Flow Device test in bronchoalveolar lavage. Mycoses . 2019;62(3):230–236. doi: 10.1111/myc.12881. - DOI - PMC - PubMed
    1. Perfect J. R., Dismukes W. E., Dromer F., et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clinical Infectious Diseases . 2010;50(3):291–322. doi: 10.1086/649858. - DOI - PMC - PubMed
    1. De Pauw B., Walsh T., Donnelly J., et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clinical Infectious Diseases . 2008;46(12):1813–1821. doi: 10.1086/588660. - DOI - PMC - PubMed

LinkOut - more resources